Pfizer Inc. (PFE)

36.60 +0.64 (+1.78%) At close: 4:02PM EDT

Pfizer Inc.

235 East 42nd Street
New York, NY 10017
United States
212 733 2323
http://www.pfizer.com

Sector(s): Healthcare
Industry: Drug Manufacturers—General
Full Time Employees: 78,500

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Albert Bourla D.V.M., DVM, Ph.D.	Chairman & CEO	7.99M	1.26M	1962
Mr. John D. Young	Group Pres & Chief Bus. Officer	3.54M	2.82M	1965
Mr. Frank A. D'Amelio	CFO & Exec. VP of Global Supply	4.52M	4M	1958
Dr. Mikael Dolsten	Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical	4.5M	N/A	1959
Ms. Angela Hwang	Group Pres of Biopharmaceuticals Group	3.97M	119.1k	1966
Ms. Jennifer B. Damico	Sr. VP, Controller & Principal Accounting Officer	N/A	N/A	1968
Ms. Lidia L. Fonseca	Exec. VP and Chief Digital & Technology Officer	N/A	N/A	1969
Mr. Charles E. Triano	Sr. VP of Investor Relations	N/A	N/A	N/A
Mr. Douglas M. Lankler	Exec. VP & Gen. Counsel	N/A	N/A	1966
Mr. Rady A. Johnson	Exec. VP and Chief Compliance, Quality & Risk Officer	N/A	N/A	1962

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Corporate Governance

Pfizer Inc.’s ISS Governance QualityScore as of April 1, 2021 is 2. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.